291 related articles for article (PubMed ID: 35815441)
1. Blood biomarkers for canine cancer, from human to veterinary oncology.
Colombe P; Béguin J; Benchekroun G; Le Roux D
Vet Comp Oncol; 2022 Dec; 20(4):767-777. PubMed ID: 35815441
[TBL] [Abstract][Full Text] [Related]
2. CDC6: A novel canine tumour biomarker detected in circulating extracellular vesicles.
Andriessen A; Bongiovanni L; Driedonks TAP; van Liere E; Seijger A; Hegeman CV; van Nimwegen SA; Galac S; Westendorp B; Nolte-'t Hoen ENM; de Bruin A
Vet Comp Oncol; 2022 Jun; 20(2):381-392. PubMed ID: 34743398
[TBL] [Abstract][Full Text] [Related]
3. Novel Noninvasive Diagnostics.
Wiley C; Wise CF; Breen M
Vet Clin North Am Small Anim Pract; 2019 Sep; 49(5):781-791. PubMed ID: 31280902
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive Blood-Based Cancer Detection in Veterinary Medicine.
Flory A; Wilson-Robles H
Vet Clin North Am Small Anim Pract; 2024 May; 54(3):541-558. PubMed ID: 38195361
[TBL] [Abstract][Full Text] [Related]
5. Response evaluation criteria for solid tumours in dogs (v1.0): a Veterinary Cooperative Oncology Group (VCOG) consensus document.
Nguyen SM; Thamm DH; Vail DM; London CA
Vet Comp Oncol; 2015 Sep; 13(3):176-83. PubMed ID: 23534501
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and predictive markers in canine tumours: rationale and relevance. A review.
Mukaratirwa S
Vet Q; 2005 Jun; 27(2):52-64. PubMed ID: 16022341
[TBL] [Abstract][Full Text] [Related]
7. The application of circulating tumor cells detecting methods in veterinary oncology.
Chmielewska M; Łosiewicz K; Socha P; Mecik-Kronenberg T; Wasowicz K
Pol J Vet Sci; 2013; 16(1):141-51. PubMed ID: 23691590
[TBL] [Abstract][Full Text] [Related]
8. Genomic analysis across 53 canine cancer types reveals novel mutations and high clinical actionability potential.
Sakthikumar S; Warrier M; Whitley D; Facista S; Adkins J; Aman S; Tsinajinnie D; Duran N; Siravegna G; Ahmed Z; Day K; Jenkins B; Patel N; Ryden K; Nadai J; Banovich K; Powers B; Edwards J; Steinberg J; Fielder S; Wong S; Byron SA; Izatt T; Zismann V; Boateng M; Zhu Z; Chuang HY; Trent JM; Haworth D; Chon E; Hendricks W; Wang G
Vet Comp Oncol; 2024 Mar; 22(1):30-41. PubMed ID: 38053317
[TBL] [Abstract][Full Text] [Related]
9. Increased plasma DR-70 (fibrinogen-fibrin degradation products) concentrations as a diagnostic biomarker in dogs with neoplasms.
Ke CH; Sio KM; Wu CH; Xia YY; Lee JJ; Hu CH; Liu CC; Lu CL; Cheng CL; Lin KH; Tomiyasu H; Wang YS; Lin CS
J Vet Intern Med; 2023; 37(6):2391-2401. PubMed ID: 37837297
[TBL] [Abstract][Full Text] [Related]
10. Canine paediatric oncology: retrospective assessment of 9522 tumours in dogs up to 12 months (1993-2008).
Schmidt JM; North SM; Freeman KP; Ramiro-Ibañez F
Vet Comp Oncol; 2010 Dec; 8(4):283-92. PubMed ID: 21062410
[TBL] [Abstract][Full Text] [Related]
11. Cancer detection in clinical practice and using blood-based liquid biopsy: A retrospective audit of over 350 dogs.
Flory A; McLennan L; Peet B; Kroll M; Stuart D; Brown D; Stuebner K; Phillips B; Coomber BL; Woods JP; Miller M; Tripp CD; Wolf-Ringwall A; Kruglyak KM; McCleary-Wheeler AL; Phelps-Dunn A; Wong LK; Warren CD; Brandstetter G; Rosentel MC; DiMarzio LR; O'Kell AL; Cohen TA; Grosu DS; Chibuk J; Tsui DWY; Chorny I; Rafalko JM
J Vet Intern Med; 2023 Jan; 37(1):258-267. PubMed ID: 36661398
[TBL] [Abstract][Full Text] [Related]
12. The relevance of liquid biopsy in surgical oncology: The application of perioperative circulating nucleic acid dynamics in improving patient outcomes.
Jordan PR; O'Leary DP; Fleming CA; Wang J; Redmond HP
Surgeon; 2022 Aug; 20(4):e163-e173. PubMed ID: 34362650
[TBL] [Abstract][Full Text] [Related]
13. Quantification of plasma cell-free DNA levels in dogs with various tumors.
Tagawa M; Shimbo G; Inokuma H; Miyahara K
J Vet Diagn Invest; 2019 Nov; 31(6):836-843. PubMed ID: 31585514
[TBL] [Abstract][Full Text] [Related]
14. Genomic and proteomic profiling for cancer diagnosis in dogs.
Morris JS
Vet J; 2016 Sep; 215():101-9. PubMed ID: 26848120
[TBL] [Abstract][Full Text] [Related]
15. Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease.
Selting KA; Sharp CR; Ringold R; Knouse J
Vet Comp Oncol; 2015 Dec; 13(4):373-84. PubMed ID: 23859156
[TBL] [Abstract][Full Text] [Related]
16. Cancer antigen 15/3: possible diagnostic use in veterinary clinical oncology. Preliminary study.
Marchesi MC; Manuali E; Pacifico E; Ferri C; Romagnoli M; Mangili V; Fruganti G
Vet Res Commun; 2010 Jun; 34 Suppl 1():S103-6. PubMed ID: 20432064
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy can detect BRCA2 gene variants in female dogs with mammary neoplasia.
de Oliveira JR; Colombo J; Gonçalves FM; de Carvalho LAL; Costa DS; Henrique T; Novais AA; Moschetta-Pinheiro MG; Chuffa LGA; Coutinho LL; Santana ÁE; Zuccari DAPC
Vet Comp Oncol; 2022 Mar; 20(1):164-171. PubMed ID: 34328705
[TBL] [Abstract][Full Text] [Related]
18. The use of minimally invasive biomarkers for the diagnosis and prognosis of hepatocellular carcinoma.
Trevisan França de Lima L; Broszczak D; Zhang X; Bridle K; Crawford D; Punyadeera C
Biochim Biophys Acta Rev Cancer; 2020 Dec; 1874(2):188451. PubMed ID: 33065194
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine in Veterinary Science.
Chon E; Hendricks W; White M; Rodrigues L; Haworth D; Post G
Vet Clin North Am Small Anim Pract; 2024 May; 54(3):501-521. PubMed ID: 38212188
[TBL] [Abstract][Full Text] [Related]
20. Circulating microRNA-214 and -126 as potential biomarkers for canine neoplastic disease.
Heishima K; Ichikawa Y; Yoshida K; Iwasaki R; Sakai H; Nakagawa T; Tanaka Y; Hoshino Y; Okamura Y; Murakami M; Maruo K; Akao Y; Mori T
Sci Rep; 2017 May; 7(1):2301. PubMed ID: 28536479
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
